Veina Inc. is developing a blood-draw syringe designed to reduce hemolysis during collection by modulating aspiration pressure. The company says it has iterated the device with nurses to improve sample quality without adding steps or workflow burden for clinicians and lab teams.
NextVein LLCBased in the United States, NextVein develops and supplies near-infrared vein finders that project a patient’s vein pattern onto the skin for clearer IV access and blood-draw guidance. Its V800NV is a lightweight handheld system that converts to hands-free use, while the company backs its equipment with U.S.-based service and the Total Protection Plan. NextVein serves healthcare settings ranging from hospitals and infusion clinics to dental practices and long-term care facilities.HUNTINGTON, NY
AccuVein, IncAccuVein develops near-infrared, laser-based vein visualization systems that project real-time images of superficial veins, valves, and bifurcations to guide vascular access and aesthetic procedures. Based in Medford, New York, the company’s patented True Center™ technology keeps its devices permanently aligned without user calibration, helping clinicians see the vein centerline with each use. AccuVein also emphasizes healthcare equity, highlighting technology designed to provide consistent vein images across skin tones.MEDFORD, NY
FASSFounded by registered emergency-room nurse Hilario Castillo, FASS develops patented multi-needle safety syringes designed to make injections quicker and safer. Its pre-attached-needle system eliminates manual needle switching, a feature aimed at reducing needlestick injuries and streamlining care in high-pressure settings such as emergency rooms and psychiatric facilities.
True Concepts Medical TechnologiesFounded in 2017 by critical-care nurse Mick Hopkins after witnessing repeated care-delivery errors, True Concepts Medical Technologies develops medical devices designed by clinicians for clinicians. The Dayton company focuses on high-risk moments such as sepsis diagnosis and sudden cardiac arrest, with its D’VIA blood-collection system and Dual Chamber Syringe aimed at reducing contamination, delay, and human error. Its team holds 30 U.S. and international patents granted or pending across 10 countries.